Christopher Growe: And then just one final question, the production of TDPs. Is that a onetime factor, do those continue, just want to understand how that could affect the business in the future? And I am finished here, thank you.
Paul Rode: Sure. Yes, those specifically related to a contract period that has now passed. So it’s basically a minimum volume commitment that is over a contract period. So we would not — but we are not expecting to have further production attainment fees as we go forward.
Christopher Growe: Thank you.
Operator: Thank you. Our next question will come from John Baumgartner with Mizuho Securities. Your line is open.
John Baumgartner: Good morning, thanks for the question. I guess I just wanted to touch, first off, on your change in the data providers, especially the move to Numerator. What have you sort of learned if anything from seeing those expanded, the data, the insights there, are you thinking any differently about penetration now, are you reassessing how or how much you can mark up on the brand going forward, is there any impact on how you think about channel expansion, just anything there would be helpful? Thank you.
Darcy H. Davenport: John, I would love to get this question next quarter. We just changed — we are — it is a ton of new information. Our focus for the last quarter has really been reconciling the old data with the new data, making sure that we feel good about it. So that has really been our focus. We are — the team is digging in to really mine the data because I think you know this, is that there is a ton of wonderful kind of insights in there, but we’ve only gotten a really — the top level at this point. The reason — the main reason for the switch is it’s at — both Numerator and IRI actually better — we have better coverage over our business, especially when it comes to e-commerce and specialty. So it was a good move for us just from a coverage standpoint. And then just the depth of insights that I think we’re going to get from on the Numerator side will be great. But we haven’t even scratched the surface so far right now. So ask me that next quarter.
John Baumgartner: Okay. So I’ll save that for next quarter. And my follow-up on the innovation and the Good Night product. I think it’s a big step for Premier moving into functional as opposed to just flavor introductions. I imagine there’s likely more on the way from that pipeline. But based on the research you’ve done, how are you thinking about the role that Premier and Dymatize can play in functional going forward, are there certain segments of functional, are you seeing lend better to one or the other? And then is it fair to think these products will be at least gross margin neutral, if not accretive, when they get to a normalized basis? Thank you.
Darcy H. Davenport: Yes. So we don’t look at it necessarily on functional or not functional. We — our innovation strategy is all about incrementality. So if you think of looking at our pipeline, it’s either incremental users, so incremental consumers or incremental occasions. This one is perfectly aligned to the occasions side of things. I think we will also get some incremental users, but this is all about occasions. Our 30-gram shakes are mostly consumed in the morning. Obviously, Good Night is a nighttime beverage. So this is a limited launch. We are — it’s three flavors on RTDs, one on powder. And it is just a test launch this year. So we’re kind of dipping our toe in it. Early results — very early are encouraging. I think it’s exciting to see some of the online reviews and consumers really getting it, really understanding that this is designed to be a new occasion.
